| Pharmaceutical Information |
| Drug Name |
Zanamivir |
| Drug ID |
BADD_D02380 |
| Description |
A guanido-neuraminic acid that is used to inhibit neuraminidase. |
| Indications and Usage |
For the prevention and treatment of influenza A and B. |
| Marketing Status |
Prescription |
| ATC Code |
J05AH01 |
| DrugBank ID |
DB00558
|
| KEGG ID |
D00902
|
| MeSH ID |
D053243
|
| PubChem ID |
60855
|
| TTD Drug ID |
D00NPP
|
| NDC Product Code |
0173-0681; 63379-028 |
| Synonyms |
Zanamivir | 2,3-Didehydro-2,4-Dideoxy-4-Guanidinyl-N-Acetylneuraminic Acid | 4-Guanidino-2,4-Dideoxy-2,3-Didehydro-N-Acetylneuraminic Acid | 5-Acetylamino-2,6-Anhydro-4-Guanidino-3,4,5-Trideoxy-D-Galacto-Non-Enoic Acid | 4-Guanidino-Neu5Ac2en | 4 Guanidino Neu5Ac2en | 2,3-Didehydro-2,4-Dideoxy-4-Guanidino-N-Acetyl-D-Neuraminic Acid | 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic Acid | 4 Guanidino 2 Deoxy 2,3 Didehydro N Acetylneuraminic Acid | Acid, 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic | Relenza | GG 167 | GG167 | GG-167 |
|
| Chemical Information |
| Molecular Formula |
C12H20N4O7 |
| CAS Registry Number |
139110-80-8 |
| SMILES |
CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
